 | Heron Therapeutics (NASDAQ:HRTX) Shares Gap Up to $8.53
americanbankingnews.com - January 21 at 11:50 AM |
| Heron Therapeutics (NASDAQ:HRTX) Sets New 52-Week Low at $8.22
americanbankingnews.com - January 14 at 1:54 PM |
| Heron Therapeutics (NASDAQ:HRTX) Shares Gap Up to $8.50
americanbankingnews.com - January 13 at 10:46 AM |
 | Why Heron Therapeutics Shares Rose Nearly 15% This Week
finance.yahoo.com - December 9 at 5:58 PM |
 | Heron Therapeutics: FDA Approves Expanded Indication For ZYNRELEF
nasdaq.com - December 9 at 12:58 PM |
 | FDA Approves Indication Expansion For Heron Therapeutics' Post-Op Pain Med
markets.businessinsider.com - December 9 at 12:58 PM |
| Heron Therapeutics Announces FDA Approval of a Significant Indication Expansion for ZYNRELEF®
finance.yahoo.com - December 9 at 12:58 PM |
| 2 Short-Squeeze Candidates That Could Go Parabolic Soon
finance.yahoo.com - December 9 at 12:58 PM |
| Heron Therapeutics Announces Submission of HTX-019 NDA for the Prevention of Postoperative Nausea and Vomiting to FDA
finance.yahoo.com - November 18 at 8:11 AM |
| Heron Therapeutics to Present at Upcoming Investor Conferences
finance.yahoo.com - November 11 at 6:14 PM |
| Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2021 and Highlights Recent Corporate Updates
finance.yahoo.com - November 3 at 6:52 PM |
|
| Heron Therapeutics to Report Third Quarter 2021 Financial Results on Wednesday, November 3, 2021
finance.yahoo.com - October 28 at 9:44 AM |
 | HRTX
seekingalpha.com - October 28 at 12:33 AM |
| SHAREHOLDER ALERT: HRTX EQT FRED: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
finance.yahoo.com - October 26 at 1:58 AM |
| Bluebird Bio or Heron Therapeutics: Which Stock Is the Better Comeback Play?
finance.yahoo.com - October 11 at 1:44 PM |
| Heron Therapeutics Inc Shares Near 52-Week Low - Market Mover
nasdaq.com - October 9 at 7:28 PM |
| Heron Therapeutics Announces Filing of a Supplemental New Drug Application for Significant Expansion of ZYNRELEF® Indication Statement Based on Successful Outcome of FDA Type C Meeting
finance.yahoo.com - October 4 at 1:12 PM |
| HRTX Oct 2021 13.000 put
finance.yahoo.com - September 29 at 4:30 PM |
 | Heron Therapeutics's Return On Capital Employed Overview
benzinga.com - September 21 at 2:33 PM |
| 2 “Strong Buy” Stocks With Heavy Short Interest
finance.yahoo.com - September 13 at 10:20 PM |
| Some Heron Therapeutics, Inc. (NASDAQ:HRTX) Analysts Just Made A Major Cut To Next Year's Estimates
nasdaq.com - August 15 at 4:50 PM |
| These Analysts Just Made A Significant Downgrade To Their Heron Therapeutics, Inc. (NASDAQ:HRTX) EPS Forecasts
finance.yahoo.com - August 15 at 4:50 PM |
| Heron Therapeutics (HRTX) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - August 9 at 1:26 PM |
| Heron Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2021 and Highlights Recent Corporate Updates
finance.yahoo.com - August 9 at 8:26 AM |
| Heron Therapeutics (NASDAQ:HRTX) Share Prices Have Dropped 66% In The Last Three Years
finance.yahoo.com - July 31 at 2:13 PM |
| Will Heron Therapeutics (HRTX) Report Negative Q2 Earnings? What You Should Know
finance.yahoo.com - July 28 at 7:19 PM |
| Heron Therapeutics Announces Publication of Results from HOPE (Helping Opioid Prescription Elimination), Showing ZYNRELEF™ Minimizes the Need for Opioids in a Real-World Setting, With 95% of Patients Experiencing an Opioid-free Recovery
finance.yahoo.com - July 28 at 7:19 PM |
| Heron Therapeutics' Zynrelef Shows Reduction In Post-Op Pain, Opioid Use Compared To Bupivacaine In Old-Aged Patients
markets.businessinsider.com - July 22 at 8:14 AM |
| Heron Therapeutics Announces Publication Showing Reduction of Pain and Opioid Use Compared to Bupivacaine in Patients 65 and Older with ZYNRELEF™
finance.yahoo.com - July 21 at 5:51 PM |
 | HRTX Jul 2021 20.000 call
uk.finance.yahoo.com - July 17 at 9:41 PM |
| Heron Therapeutics, Inc. Common Stock (HRTX)
nasdaq.com - July 16 at 10:47 PM |
| Heron Therapeutics Executes Contract With Apexus For Non-opioid Option ZYNRELEF
markets.businessinsider.com - July 6 at 10:06 AM |
| Heron Therapeutics Announces 340B Prime Vendor Contract with Apexus for ZYNRELEF™
finance.yahoo.com - July 6 at 10:06 AM |
|
| HRTX Jul 2021 17.000 call
uk.finance.yahoo.com - July 3 at 8:31 AM |
| Heron Therapeutics Announces U.S. Commercial Launch, Availability Of ZYNRELEF For Management Of Postoperative Pain For Up To 72 Hours
benzinga.com - July 1 at 1:18 PM |
| Heron Therapeutics Announces U.S. Commercial Launch and Availability of ZYNRELEF™ for the Management of Postoperative Pain for up to 72 Hours
finance.yahoo.com - July 1 at 1:18 PM |
| Here's Why Shareholders May Want To Be Cautious With Increasing Heron Therapeutics, Inc.'s (NASDAQ:HRTX) CEO Pay Packet
nasdaq.com - June 11 at 5:33 PM |
| Heron Therapeutics to Present at the 2021 Jefferies Virtual Investor Conference
finance.yahoo.com - May 25 at 6:07 PM |
| Heron Therapeutics Announces $150 Million Convertible Debt Financing
finance.yahoo.com - May 25 at 1:06 PM |
| Heron's stock rises after FDA approval of surgical medicine
finance.yahoo.com - May 13 at 2:25 PM |
 | Heron Therapeutics Gets FDA OK of Zynrelef for Postoperative Pain >HRTX
marketwatch.com - May 13 at 9:25 AM |
| Heron Therapeutics' Zynrelef Gets FDA Approval For Managing Post-Operative Pain For 72 Hours
nasdaq.com - May 13 at 9:25 AM |
| Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF™ (HTX-011) for the Management of Postoperative Pain for up to 72 Hours
finance.yahoo.com - May 13 at 9:25 AM |
| Heron Stock Trading Higher After Q1 Earnings, Ahead Of HTX-011 Decision Scheduled This Week
benzinga.com - May 10 at 4:15 PM |
| Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2021 and Highlights Recent Corporate Updates
finance.yahoo.com - May 10 at 4:15 PM |
| Heron Therapeutics (HRTX) Reports Q1 Loss, Misses Revenue Estimates
finance.yahoo.com - May 10 at 4:15 PM |
| Why Heron Therapeutics Stock Jumped Today
finance.yahoo.com - May 10 at 4:15 PM |
| HRTX Makes Notable Cross Below Critical Moving Average
nasdaq.com - May 4 at 1:32 PM |
| Will Heron Therapeutics (HRTX) Report Negative Q1 Earnings? What You Should Know
finance.yahoo.com - April 28 at 1:40 PM |
| Heron Therapeutics'(NASDAQ:HRTX) Share Price Is Down 43% Over The Past Three Years.
nasdaq.com - April 28 at 8:39 AM |
